DR. HUBERT CHEN, M.D.
Osteopathic Medicine in San Francisco, CA
License number
California A70400
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California A70400
Category
Osteopathic Medicine
Type
Critical Care Medicine
License number
California A70400
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
350 Parnassus Ave Suite 609, San Francisco, CA 94143
Phone
(415) 502-6765
(415) 681-3212 (Fax)
(415) 681-3212 (Fax)
Personal information
See more information about HUBERT CHEN at radaris.comName
Address
Phone
3051 Bostonian Dr, Los Alamitos, CA 90720
6670 Ivy Ln, San Jose, CA 95129
5488 Sonoma Pl, San Diego, CA 92130
425 S Stoneman Ave APT 4, Alhambra, CA 91801
4134 Pacific Coast Hwy, Torrance, CA 90505
Organization information
See more information about HUBERT CHEN at bizstanding.comHubert Chen MD
1600 Divisadero St, San Francisco, CA 94115
Industry:
Internist
Phone:
(415) 885-7447 (Phone)
Hubert Chih-Hsin Chen
Professional information
Hubert Chih-Hsin Chen, San Francisco CA
Specialties:
Internal Medicine, Endocrinology, Diabetes & Metabolism, Critical Care Medicine, Pulmonary Disease
Work:
UCSF Medical Center / Moffitt-Long Hospitals
1600 Divisadero St, San Francisco, CA 94115 UCSF Medical Center / Moffitt-Long Hospitals
521 Parnassus Ave, San Francisco, CA 94143
1600 Divisadero St, San Francisco, CA 94115 UCSF Medical Center / Moffitt-Long Hospitals
521 Parnassus Ave, San Francisco, CA 94143
Education:
Stanford University (1998)
Hubert Chen, San Francisco CA
Specialties:
Internist
Address:
350 Parnassus Ave, San Francisco, CA 94117
1 Dna Way, South San Francisco, CA 94080
1 Dna Way, South San Francisco, CA 94080
Education:
Harvard University - Master of Public Health
Stanford University, School of Medicine - Doctor of Medicine
Stanford University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Critical Care Medicine (Internal Medicine), American Board of Internal Medicine Sub-certificate in Pulmonary Disease (Internal Medicine)
Dr. Hubert Chen, San Francisco CA - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine, Pulmonology
Address:
350 Parnassus Ave SUITE 609, San Francisco 94117
(415) 502-6765 (Phone), (415) 681-3212 (Fax)
UCSF Medical Center PUL
400 Parnassus Ave, San Francisco 94143
(415) 353-2961 (Phone)
(415) 502-6765 (Phone), (415) 681-3212 (Fax)
UCSF Medical Center PUL
400 Parnassus Ave, San Francisco 94143
(415) 353-2961 (Phone)
Certifications:
Critical Care Medicine, 2005, Internal Medicine, 2001, Pulmonary Disease, 2004
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
350 Parnassus Ave SUITE 609, San Francisco 94117
UCSF Medical Center PUL
400 Parnassus Ave, San Francisco 94143
California Pacific Medical Center - California
3700 California St, San Francisco 94118
California Pacific Medical Center - Pacific
2333 Buchanan St, San Francisco 94115
UCSF Medical Center PUL
400 Parnassus Ave, San Francisco 94143
California Pacific Medical Center - California
3700 California St, San Francisco 94118
California Pacific Medical Center - Pacific
2333 Buchanan St, San Francisco 94115
Education:
Medical School
Stanford University School Of Medicine
Graduated: 1998
Stanford University
Graduated: 2001
University Ca
Graduated: 2005
Stanford University School Of Medicine
Graduated: 1998
Stanford University
Graduated: 2001
University Ca
Graduated: 2005
Hubert Chen
Location:
San Francisco Bay Area
Industry:
Hospital & Health Care
Methods And Compositions For Modulating Carbohydrate Metabolism
US Patent:
2007012, May 31, 2007
Filed:
Dec 12, 2006
Appl. No.:
11/609810
Inventors:
Robert Farese - San Francisco CA, US
Hubert Chen - San Francisco CA, US
Hubert Chen - San Francisco CA, US
International Classification:
A61K 38/22
US Classification:
514012000
Abstract:
Methods and compositions for modulating carbohydrate metabolism in a host are provided. In the subject methods, diacylglycerol acyltransferase (DGAT) activity (specifically DGAT1 activity) is modulated, e.g., reduced or enhanced, to achieve a desired insulin and/or leptin sensitivity, thereby modulating carbohydrate metabolism, e.g., increasing or decreasing blood glucose levels, glucose uptake into cells and assimilation into glycogen. Also provided are pharmaceutical compositions for practicing the subject methods. The subject methods and compositions find use in a variety of applications, including the treatment of hosts suffering conditions associated with abnormal carbohydrate metabolism, such as obesity or diabetes.
Methods And Compositions For Modulating Carbohydrate Metabolism
US Patent:
2003015, Aug 14, 2003
Filed:
Nov 5, 2002
Appl. No.:
10/289172
Inventors:
Robert Farese - San Francisco CA, US
Hubert Chen - San Francisco CA, US
Hubert Chen - San Francisco CA, US
International Classification:
A01K067/027, A61K038/28, A61K038/17
US Classification:
800/018000, 514/002000, 514/003000
Abstract:
Methods and compositions for modulating carbohydrate metabolism in a host are provided. In the subject methods, diacylglycerol acyltransferase (DGAT) activity (specifically DGAT1 activity) is modulated, e.g., reduced or enhanced, to achieve a desired insulin and/or leptin sensitivity, thereby modulating carbohydrate metabolism, e.g., increasing or decreasing blood glucose levels, glucose uptake into cells and assimilation into glycogen. Also provided are pharmaceutical compositions for practicing the subject methods. The subject methods and compositions find use in a variety of applications, including the treatment of hosts suffering conditions associated with abnormal carbohydrate metabolism, such as obesity or diabetes.
Methods And Compositions For Modulating Sebaceous Glands
US Patent:
2003010, May 29, 2003
Filed:
Oct 21, 2002
Appl. No.:
10/278733
Inventors:
Steven Smith - San Francisco CA, US
Hubert Chen - San Francisco CA, US
Robert Farese - San Francisco CA, US
Hubert Chen - San Francisco CA, US
Robert Farese - San Francisco CA, US
International Classification:
A61K031/00, A61K048/00
US Classification:
514/001000, 514/044000
Abstract:
Methods and compositions for modulating sebaceous gland activity in a host are provided. In the subject methods, DGAT1 activity is modified, e.g., reduced or enhanced, to achieve the desired sebaceous gland activity modulation, e.g., reduction in sebum production and/or sebaceous gland size. Also provided are pharmaceutical preparations for use in practicing the subject methods. The subject methods and compositions find use in a variety of applications, including the treatment of hosts suffering from sebaceous gland related conditions, e.g., acne and related conditions.
Hubert Chen
Location:
San Francisco Bay Area
Industry:
Internet
Hubert Chen
Location:
San Francisco Bay Area
Industry:
Computer Hardware
Languages:
Chinese
Osteopathic Medicine licenses in California
PAUL A FITZGERALD MD INC, Osteopathic Medicine, 350 Parnassus Ave SUITE 710, San Francisco, CA 94117